Project Grant HT94252510837
Award Date 10/1/25
Completion Date 9/30/27
Dollars Obligated $488K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Tacoma, WA 98402, USA
Similar Awards
- The U.S. Department of Defense's Defense Health Agency awarded a $488,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Geneva Foundation, a non-profit organization. The grant, awarded on July 1, 2024, supports research to investigate novel mechanisms of regulating the PAX3-FOXO1 fusion oncogene in rhabdomyosarcoma, a type of soft tissue cancer. The research aims to advance treatments for this rare and aggressive form of cancer, with a projected...
- This Project Grant award for $366,000.00, awarded on Sep 30, 2024 by the Defense Health Agency, supports research conducted by The Geneva Foundation to identify functional structural variants that influence therapy outcomes for human castration-resistant prostate cancer. The award is funded through the Military Medical Research and Development program (CFDA 12.420), which supports a broad range of biomedical research initiatives to improve health outcomes for military service members,...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $2,198,698 to The Geneva Foundation to conduct research on extracorporeal immunomodulation to reduce inflammation after severe burns, inhalation injury, and septicemia. The 3-year project, running from November 1, 2025 to October 31, 2028, aims to develop innovative medical solutions to address critical health challenges for military service members...
- This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $1,065,392.00 to The Geneva Foundation to conduct research on "LOCAL SLEEP IN THE WAKING BRAIN: A NOVEL TARGET FOR COGNITIVE FATIGUE". The project period runs from June 1, 2024 to May 31, 2028. As a non-profit research organization, The Geneva Foundation will perform foundational biomedical research investigating innovative treatments for...
- The Geneva Foundation received a $453,029 Project Grant award from the Department of the Army Medical Command on February 1, 2021 to improve the therapeutic index of antibody drug conjugates targeting metastatic breast cancer. Funded through January 31, 2024 under the Military Medical Research and Development program (CFDA 12.420), this award will support the Foundation's work to transform healthcare and investigate medical solutions for the battlefield by developing more effective targeted...
- The Geneva Foundation received a $4,676,544 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to develop and validate innate immunome-targeted therapies to create a pro-survival and organ-protective phenotype after hemorrhage at the point of injury. Specifically, the Foundation will investigate immunotherapy approaches for hemorrhage treatments using innate immunome-targeted therapies from July 1, 2023 to...
- This Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $909,510.00 in funding to The Geneva Foundation for the project "PRECISION THERAPY FOR THE ERADICATION OF BRAIN METASTATIC BREAST CANCER". The award period runs from May 1, 2025 through April 30, 2028. The Geneva Foundation, a non-profit medical research organization, will conduct advanced biomedical research to develop innovative therapeutic...
- The Geneva Foundation was awarded a $362,100 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program to conduct research toward the dual targeting of HER2 and androgen receptor in patients with high-risk, hormone-naive prostate cancer with curative intent. The two-year grant project period runs from June 1, 2022 to May 31, 2024. Through this funding, The Geneva Foundation will perform applied medical research investigating...
- The Defense Health Agency awarded a $410,000 Project Grant titled "Localized and Inflammation-Responsive Immunotherapy of VCA Rejection" to The Geneva Foundation, a 501(c)3 non-profit organization that supports medical research and education for the U.S. military. This grant is part of the "Military Medical Research and Development" program (CFDA 12.420), which funds basic, applied, and advanced biomedical research to transform healthcare for Service Members and the public...
- The U.S. Defense Health Agency awarded a $325,650 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Geneva Foundation, a nonprofit organization based in Tacoma, Washington. The grant supports an assessment of changes in the human blood proteome (the entire set of proteins expressed by an organism) following total sleep deprivation over a project period of 2 years from March 2025 to February 2027. The Geneva Foundation, which specializes in medical...